Medtronic PLC at Oppenheimer Healthcare Conference (Virtual) Transcript
Hi, everyone. I'm Steve Lichtman, medical device analyst at Oppenheimer. I apologize for the slight technical delay. Welcome to the 31st Annual Oppenheimer Healthcare Conference. Very happy to have with us up next, Medtronic. With us today is Sean Salmon. Sean, I think you win the award for longest title of the day, Executive Vice President, and President, Diabetes, and President, Cardiovascular Portfolio. So needless to say, we've got a lot of topics that we can hit today. So thanks for joining us, Sean. And if you have any questions, for those dialed in, please keep them in, and I'll make sure to get them right over to Sean.
Questions & Answers
So first, I thought we would start, Sean, with diabetes. Maybe start at a high level from a market perspective. What do you believe has been the biggest headwind to type 1 adoption historically? And what do you see as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |